The treatment of ductal carcinoma in situ (DCIS) of the breast;De behandeling van ductaal carcinoma in situ (DCIS) van de mamma

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 44, 2003, Pages 2157-2161

  Westenberg, A H ^a   Rutgers, E J Th ^b   Peterse, J L ^b   Hendriks, J H C L ^c   Beex, L V A M ^c   Van Tienhoven, G ^d  

^a Radiother Samenwerkingsverband   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; PROGNOSIS; RISK FACTOR;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; HUMANS; MAMMOGRAPHY; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0242299259     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. The management of ductal carcinoma in situ (DCIS). CMAJ 1998;158 Suppl 3:S27-34.
2. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000;355:528-33.
3. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52.
4. Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-63.
5. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31A:1425-7.
6. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70.
7. Voogd AC, Crommelin MA, Repelaer van Driel OJ, Tutein Nolthenius-Puylaert MCBJE, Heijden LH van der, Coebergh JWW. Trends in incidentie en behandelbeleid van ductaal carcinoma in situ van de mamma in Zuidoost-Nederland. Ned Tijdschr Geneeskd 2000; 144:659-63.
8. Sharma S, Hill ADK, McDermott EW, O'Higgins NJ. Ductal carcinoma in situ of the breast - current management. Eur J Surg Oncol 1997;23:191-7.
9. Fisher DE, Schnitt SJ, Christian R, Harris JR, Henderson IC. Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy. Cancer 1993;71:3025-8.
10. Chan KC, Knox WF, Sinha G, Gandhi A, Barr L, Baildam AD, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 2001;91:9-16.
11. Landelijk Evaluatieteam voor bevolkingsonderzoek naar Borstkanker. Landelijke evaluatie van het bevolkingsonderzoek op borstkanker in Nederland 1999. Instituut voor Maatschappelijke Gezondheidszorg. Rotterdam: Erasmus Universiteit Rotterdam; 1999.
12. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987;60:2751-60.
13. Bhathal PS, Brown RW, Lesueur GC, Russell IS. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer 1985;51:271-8.
14. Fentiman IS. Trials of treatment for non-invasive breast cancer. Recent Results Cancer Res 1998;152:135-42.
15. Fisher B, Costantino J, Redmond CPH, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
16. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, et al. Tamoxifen in treatment of intraductal breast cancer. National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993-2000.
17. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001;28:400-18.
18. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval Ch, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71.
19. Solin LJ, Fourquet A, Vicini FA, Haffty BG, Taylor M, McCormick B, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001; 50:991-1002.
20. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-74.
21. Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer 1999;85:427-31.
22. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991;21:289-92.
23. Fonseca R, Hartmann LC, Petersen IA, Donohue JH, Crotty TB, Gisvold JJ. Ductal carcinoma in situ of the breast. Ann Intern Med 1997;127:1013-22.
24. Fish EB, Chapman JAW, Miller NA, Link MA, Fishell E, Wright B, et al. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol 1998;5:724-32.
25. Szelei-Stevens KA, Kuske RR, Yantsos VA, Cederbom GJ, Bolton JS, Fineberg BB. The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy. Int J Radiat Oncol Biol Phys 2000;48:943-9.
26. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. J Clin Oncol 2002;20:2736-44.
27. Holland R, Hendriks JHCL. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-92.
28. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
29. Kwaliteitsinstituut voor de Gezondheidszorg CBO. Het mammacarcinoom: richtlijn voor screening en diagnostiek. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO; 1999.
30. Pijnappel RM, Graaf PW de, Dalen A van, Hennipman A, Tweel JG van den, Mali WPThM. Digitale röntgengestuurde dikkenaald-biopsie als alternatief voor chirurgische biopsie bij patiënten met niet-palpabele mammografische afwijkingen. Ned Tijdschr Geneeskd 1996;140:1948-52.
31. Dixon JM, Ravisekar O, Cunningham M, Anderson EDC, Anderson TJ, Brown HK. Factors affecting outcome of patients with impalpable breast cancer detected by breast screening. Br J Surg 1996;83:997-1001.
32. Verkooijen HM, Peeters PH, Buskens E, Koot VC, Borel Rinkes IH, Mali WPThM, et al. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer 2000;82:1017-21.
33. Bijker N, Peterse JL, Duchateau L, Robanus-Maandag EC, Bosch CAJ, Duval C, et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001; 84:539-44.
34. The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997;80:1798-802.
35. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, Vijver MJ van de, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80.
36. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999;340: 1455-61.
37. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Bogaert W van den, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-87.
38. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 2000;88:946-54.
39. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;715-20.
40. Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1331-5.
41. Kwaliteitsinstituut voor de Gezondheidszorg CBO. Richtlijn behandeling van het mammacarcinoom. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO; 2002.
42. Rutgers EJTh, Nortier JWR, Tuut MK, Tienhoven G van, Struikmans H, Bontenbal M, et al. CBO-richtlijn 'Behandeling van het mammacarcinoom'. Ned Tijdschr Geneeskd 2002;146:2144-51.